APA (7th ed.) Citation

SP, D., AL, R., AP, C., HJ, W., MA, D., M, G., . . . WD, T. (2022). Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma. Nature communications, 13(1), 3477. https://doi.org/10.1038/s41467-022-30874-8

Chicago Style (17th ed.) Citation

SP, D'Angelo, et al. "Pilot Study of Bempegaldesleukin in Combination with Nivolumab in Patients with Metastatic Sarcoma." Nature Communications 13, no. 1 (2022): 3477. https://doi.org/10.1038/s41467-022-30874-8.

MLA (9th ed.) Citation

SP, D'Angelo, et al. "Pilot Study of Bempegaldesleukin in Combination with Nivolumab in Patients with Metastatic Sarcoma." Nature Communications, vol. 13, no. 1, 2022, p. 3477, https://doi.org/10.1038/s41467-022-30874-8.